-
ofTanja Banner
–
shut down
–
A new corona drug? AstraZeneca’s antibody combination could provide immediate protection against the coronavirus – filling a gap that vaccines leave open.
- A possible one new corona drug could fill a void that Corona vaccinations leave open.
- The Antibody combination AZD7442 from AstraZeneca and UCLH should immediately against Corona take effect – a phase 3 is currently runningstudy.
- Even people with impaired immune system could be the possible new corona drug in front Covid-19 protect.
–
Frankfurt – That has been going on for about a year Coronavirus Sars-CoV-2 the world in breath – now there are finally the first glimmers of hope. On December 23rd became the first Corona vaccine Approved in the EU, vaccinations have now also started. Further vaccines are currently being tested, and a statement from the European Medicines Agency (EMA) on the vaccine from Moderna is expected by January 6th. If this opinion is positive, the EU Commission is likely to counter the Moderna vaccine Corona also allow. Federal Minister of Health Jens Spahn (CDU) hopes to be able to make “anyone who wants a vaccination offer” in the middle of the year.
Corona drug: will AstraZeneca funds provide immediate protection?
But vaccinations – for all the advantages they bring – also have a decisive disadvantage: It usually takes some time for them to work, and sometimes several vaccinations are required to build up full protection. But with a possible one new corona drugby the University College London Hospitals NHS Foundation Trust (UCLH) together with the pharmaceutical company AstraZeneca was developed, it should be different.
Corona drug from AstraZeneca and UCLH: antibodies from the laboratory
In which Corona-Medically should it be about the Antibody combination AZD7442 act that of AstraZeneca was developed, as reported by the Guardian. These are not antibodies that are made in the body to fight an infection, but antibodies that are made in the laboratory. These antibody could people that dem Coronavirus were directly exposed, protect against that Disease Covid-19 to develop, it says in the “Guardian”. According to experts, this could save many lives.
UCLH virologist Catherine Houlihan leads the Phase 3 study “Storm Chaser” to the possible Corona-Medically and says: “We know that this combination of antibodies can neutralize the virus.” Therefore, the study director hopes that the injection in people who Coronavirus were exposed to one immediate protection against Covid-19 can lead. “Offering a vaccination would then be too late,” she emphasizes.
Phase 3 study for new corona drug: will participants develop Covid-19?
So far there are ten study participants who previously had Coronavirus were exposed to the possible new drug was injected, explains study leader Houlihan. Now it should be observed carefully whether the people Covid-19 develop. The is currently running at several UK hospitals and other locations around the world study. The researchers hope that the Antibody cocktail for six to twelve months against Corona can protect. Study participants receive two doses of the possible new drug against Corona – or a placebo.
The Antibodies against corona could already be approved in March or April, says the Guardian. If that Corona-Medically Approved by the authorities, it should be offered to people who have been in the past eight days Coronavirus were exposed, it is said.
If you’ve been reading the stories in the press about our two new monoclonal antibody trials and want to know more (including how to check if you’re eligible) please go to our story on the UCLH website which has full information in the FAQs: https://t.co/mZIgI0YtvI
– UCLH (@uclh) December 26, 2020
–
New corona drug could act as an emergency drug once approved
Does that work drug actually immediately against Corona, it could fill a void that vaccines can’t: That Corona-Medically from AstraZeneca and UCLH could be considered Emergency drug for treating people who have the Coronavirus were exposed and threatened with a severe course. The “Guardian” cites patients in hospitals or residents of nursing homes as examples. There you could, for example, also larger Corona outbreaks with the help of Drug bring under control, emphasizes Paul Hunter, a specialist in infectious diseases, to the “Guardian”. “Provided it is confirmed in phase 3 studies, it could play a big role in keeping people alive who would otherwise die. So it should be a big deal, ”said Hunter.
Even people who live in households with already infected people could find themselves in front of their own Covid-19 disease protect. “If you live with your elderly grandmother and someone in the household gets infected, you could give her the drug to protect her,” explains Hunter. “The advantage of this drug is that you get antibodies immediately,” emphasizes study director Houlihan.
New corona drug could also protect people with impaired immune systems
Another study (“Provent”) is underway in Great Britain, in which the UCLH is examining whether this is possible Corona-Medically also people with compromised immune systems Corona can protect. “We will look for participants who are elderly or in long-term care and who have impairments such as cancer or HIV that affect their immune system,” explains Nicky Longley, who leads the Phase 3 study “Provent”. “We want to reassure those for whom a vaccination doesn’t work that we can offer an alternative that protects just as well.”
The pharmaceutical company AstraZeneca that makes the possible new corona drug co-developed a joint venture with Oxford University Corona vaccine which could be approved in the UK in the coming days. (Tanja Banner)
–
Related posts:
Early Detection of Breast Cancer through Mammograms: Importance and ProcessDoctors there blame a hemorrhage, those in Iasi blame a nosocomial infectionCOVID-19 mRNA Vaccines and Breast Cancer Screening"New Vaccination Center Opens in Plaza Las Américas to Offer Bivalent Reinforcement Against COVID-19...
